260 related articles for article (PubMed ID: 33894351)
1. Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation.
Sun Y; Yang J; Yang T; Li Y; Zhu R; Hou Y; Liu Y
Acta Biomater; 2021 Jul; 128():447-461. PubMed ID: 33894351
[TBL] [Abstract][Full Text] [Related]
2. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
[TBL] [Abstract][Full Text] [Related]
3. Dual polymeric prodrug co-assembled nanoparticles with precise ratiometric co-delivery of cisplatin and metformin for lung cancer chemoimmunotherapy.
Yang T; Yu S; Liu L; Sun Y; Lan Y; Ma X; Zhu R; Li L; Hou Y; Liu Y
Biomater Sci; 2020 Oct; 8(20):5698-5714. PubMed ID: 32930254
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
[TBL] [Abstract][Full Text] [Related]
7. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
[TBL] [Abstract][Full Text] [Related]
8. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.
Yu H; Guo C; Feng B; Liu J; Chen X; Wang D; Teng L; Li Y; Yin Q; Zhang Z; Li Y
Theranostics; 2016; 6(1):14-27. PubMed ID: 26722370
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
Tan S; Wang G
Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
[TBL] [Abstract][Full Text] [Related]
11. Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy.
Du M; Yin J
Drug Des Devel Ther; 2022; 16():4139-4149. PubMed ID: 36506793
[TBL] [Abstract][Full Text] [Related]
12. Tumor Microenvironment Sequential Drug/Gene Delivery Nanosystem for Realizing Multistage Boosting of Cancer-Immunity Cycle on Cancer Immunotherapy.
Cao Y; Li J; Liang Q; Yang J; Zhang X; Zhang J; An M; Bi J; Liu Y
ACS Appl Mater Interfaces; 2023 Nov; 15(47):54898-54914. PubMed ID: 37963093
[TBL] [Abstract][Full Text] [Related]
13. Lung-specific exosomes for co-delivery of CD47 blockade and cisplatin for the treatment of non-small cell lung cancer.
Cui Z; Ruan Z; Zeng J; Sun J; Ye W; Xu W; Guo X; Zhang L; Song L
Thorac Cancer; 2022 Oct; 13(19):2723-2731. PubMed ID: 36054073
[TBL] [Abstract][Full Text] [Related]
14. A sulfhydryl blocking reagent BT-4 sensitizes cisplatin-based micelle prodrugs for efficient treatment of breast cancer.
Lin C; Chen Y; Zhu M; Pei J; Zhou Y; Gou M; Ouyang L
Int J Pharm; 2022 Oct; 626():122187. PubMed ID: 36100145
[TBL] [Abstract][Full Text] [Related]
15. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
16. Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid.
Liu Y; Sun J; Huang Y; Chen Y; Li J; Liang L; Xu J; Wan Z; Zhang B; Li Z; Li S
Biochem Pharmacol; 2021 Jul; 189():114453. PubMed ID: 33545119
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
[TBL] [Abstract][Full Text] [Related]
18. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes.
Chen M; Zhang Y; Chen Z; Xie S; Luo X; Li X
Acta Biomater; 2017 Feb; 49():444-455. PubMed ID: 27940163
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.
Yue T; Zheng X; Dou Y; Zheng X; Sun R; Tian Z; Wei H
BMC Cancer; 2016 Aug; 16(1):665. PubMed ID: 27549240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
